Posted in | News | Signal Processing

Northrop Grumman to Develop New ARL-E Long-Range Radar for US Army

Northrop Grumman Corporation has been selected by the U.S. Army to develop the Airborne Reconnaissance Low-Enhanced (ARL-E) Long-Range Radar.

Under terms of the indefinite delivery indefinite quantity contract, Northrop Grumman will develop a synthetic aperture radar (SAR)/ground moving target indicator (GMTI) system for the ARL-E DHC-8.

"The Long Range Radar [LRR] is a natural fit into the Northrop Grumman family of intelligence, surveillance and reconnaissance [ISR] systems and mission solutions," said Steve McCoy, vice president of tactical sensor solutions, Northrop Grumman Electronic Systems. "Our low-risk, affordable solution combines mature Active Electronically Scanned Array [AESA] technology with operationally proven hardware and software to meet all-weather and long-range ISR requirements."

Northrop Grumman's LRR solution helps enhance the Army's C4ISR capabilities by combining the proven Gen 2 Vehicle and Dismount and Exploitation Radar (VADER) back-end electronics and software with a high technology readiness level AESA to meet the demanding performance requirements of ARL-E and in particular the dismount moving target indication.

Backed by more than 70 years of experience in developing and fielding radars, Northrop Grumman's family of tactical radars provide unrelenting surveillance and precision battlefield intelligence in all types of weather and obscurants, day or night. LRR is the newest member of the tactical radar family, joining the short-range STARLite and medium-range VADER systems.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.